Stock listing
NASDAQ:MMSI Merit Medical Systems, Inc. Stock
Home listing (NASDAQ) of Merit Medical Systems, Inc.
Follow Merit Medical Systems, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MMSI
$84.34 USD -1.59 (-1.9%)
Close on Nov 20, 2026
- Day range
- $83.89 – $86.20 USDNov 20, 2026
- Volume
- 560,267 sharesNov 20, 2026
- Market cap
- $5.05B USDAt the close on Nov 20, 2026 · price × 59.92M shares outstanding
- 52-week range
- $59.74 – $94.85 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $57.35M USDMedian day 587,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MMSI · Home | $84.34 USD | -1.59 (-1.9%) | 560,267 | $84.58 | $86.20 | $83.89 | $85.93 | Close on Nov 20, 2026 |
| Frankfurt:MM3 | €76.50 EUR | -1.00 (-1.3%) | — | €76.00 | €76.50 | €76.00 | €77.50 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MMSI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $84.34 | -1.59 | -1.9% | $84.58 | $86.20 | $83.89 | 560,267 | |
| $85.93 | +1.44 | +1.7% | $84.36 | $86.35 | $83.89 | 460,107 | |
| $84.49 | -1.86 | -2.2% | $85.69 | $86.31 | $84.15 | 553,064 | |
| $86.35 | -0.28 | -0.3% | $86.90 | $87.57 | $85.89 | 473,477 | |
| $86.63 | -0.06 | -0.1% | $86.95 | $87.37 | $85.97 | 365,600 | |
| $86.69 | -1.38 | -1.6% | $88.28 | $89.53 | $85.57 | 535,554 | |
| $88.07 | +0.26 | +0.3% | $87.67 | $88.38 | $86.36 | 440,010 | |
| $87.81 | -0.61 | -0.7% | $87.97 | $89.01 | $87.21 | 480,464 | |
| $88.42 | +1.19 | +1.4% | $88.00 | $89.30 | $87.44 | 507,101 | |
| $87.23 | -2.39 | -2.7% | $88.33 | $88.96 | $87.05 | 354,017 | |
| $89.62 | -1.01 | -1.1% | $91.18 | $92.92 | $88.80 | 940,187 | |
| $90.63 | +6.47 | +7.7% | $87.03 | $91.40 | $86.04 | 1,387,205 | |
| $84.16 | -0.15 | -0.2% | $84.04 | $85.06 | $83.65 | 799,247 | |
| $84.31 | -1.93 | -2.2% | $86.26 | $86.34 | $83.72 | 1,202,811 | |
| $86.24 | -7.15 | -7.7% | $91.00 | $92.45 | $84.00 | 1,804,090 | |
| $93.39 | +1.18 | +1.3% | $93.09 | $93.78 | $91.30 | 913,665 | |
| $92.21 | -1.32 | -1.4% | $92.71 | $94.12 | $92.01 | 542,668 | |
| $93.53 | -0.67 | -0.7% | $94.20 | $94.45 | $93.12 | 684,480 | |
| $94.20 | +0.90 | +1.0% | $93.42 | $94.85 | $93.30 | 889,615 | |
| $93.30 | -0.64 | -0.7% | $93.57 | $93.87 | $92.77 | 750,600 | |
| $93.94 | +2.54 | +2.8% | $91.40 | $94.16 | $89.13 | 655,000 | |
| $91.40 | +0.22 | +0.2% | $90.43 | $92.05 | $90.00 | 543,200 | |
| $91.18 | +1.22 | +1.4% | $90.86 | $91.59 | $90.46 | 688,800 | |
| $89.96 | +0.76 | +0.9% | $88.85 | $90.74 | $88.85 | 581,000 | |
| $89.20 | -0.37 | -0.4% | $89.83 | $90.24 | $88.52 | 488,400 | |
| $89.57 | +2.41 | +2.8% | $88.45 | $90.26 | $88.42 | 707,200 | |
| $87.16 | -0.98 | -1.1% | $88.14 | $89.06 | $86.55 | 608,000 | |
| $88.14 | -1.61 | -1.8% | $90.00 | $90.99 | $87.84 | 842,200 | |
| $89.75 | +2.54 | +2.9% | $87.65 | $89.93 | $87.65 | 859,700 | |
| $87.21 | +1.96 | +2.3% | $85.41 | $87.62 | $85.41 | 480,800 | |
| $85.25 | +0.16 | +0.2% | $85.02 | $85.81 | $83.94 | 579,400 | |
| $85.09 | +0.13 | +0.2% | $84.93 | $86.01 | $84.73 | 468,100 | |
| $84.96 | -2.18 | -2.5% | $87.45 | $88.90 | $84.22 | 587,700 | |
| $87.14 | +1.77 | +2.1% | $85.40 | $87.57 | $84.74 | 699,200 | |
| $85.37 | -0.78 | -0.9% | $86.73 | $86.86 | $85.24 | 492,400 | |
| $86.15 | -0.08 | -0.1% | $86.00 | $86.87 | $85.42 | 701,700 | |
| $86.23 | -1.64 | -1.9% | $87.87 | $88.23 | $86.23 | 634,200 | |
| $87.87 | +0.87 | +1.0% | $87.04 | $88.13 | $86.33 | 731,000 | |
| $87.00 | -0.50 | -0.6% | $87.20 | $88.09 | $86.57 | 551,100 | |
| $87.50 | +0.20 | +0.2% | $87.25 | $87.95 | $86.77 | 354,000 | |
| $87.30 | +0.23 | +0.3% | $87.18 | $87.56 | $86.45 | 743,300 | |
| $87.07 | -0.19 | -0.2% | $86.96 | $88.14 | $86.93 | 611,200 | |
| $87.26 | +1.77 | +2.1% | $86.03 | $87.79 | $85.47 | 682,800 | |
| $85.49 | +0.12 | +0.1% | $85.88 | $86.23 | $84.99 | 379,900 | |
| $85.37 | -0.20 | -0.2% | $85.03 | $87.33 | $84.12 | 910,400 | |
| $85.57 | -0.57 | -0.7% | $86.40 | $86.50 | $85.23 | 319,400 | |
| $86.14 | -0.04 | 0.0% | $85.49 | $87.68 | $85.31 | 540,500 | |
| $86.18 | -0.84 | -1.0% | $86.81 | $86.81 | $85.66 | 533,100 | |
| $87.02 | +0.66 | +0.8% | $87.53 | $87.83 | $86.03 | 384,000 | |
| $86.36 | -0.11 | -0.1% | $87.49 | $88.20 | $85.40 | 443,200 | |
| $86.47 | -0.72 | -0.8% | $86.63 | $87.49 | $85.19 | 549,900 | |
| $87.19 | -0.19 | -0.2% | $86.92 | $87.64 | $86.42 | 475,600 | |
| $87.38 | -2.22 | -2.5% | $88.47 | $88.91 | $86.72 | 1,422,100 | |
| $89.60 | +1.03 | +1.2% | $87.68 | $89.69 | $87.04 | 599,600 | |
| $88.57 | -1.56 | -1.7% | $90.81 | $91.63 | $88.41 | 606,400 | |
| $90.13 | -0.55 | -0.6% | $90.42 | $92.18 | $90.07 | 908,800 | |
| $90.68 | +0.02 | 0.0% | $90.92 | $91.38 | $90.17 | 679,000 | |
| $90.66 | +0.17 | +0.2% | $90.13 | $91.34 | $90.13 | 407,600 | |
| $90.49 | +0.95 | +1.1% | $89.96 | $90.72 | $89.28 | 341,600 | |
| $89.54 | -1.00 | -1.1% | $89.58 | $90.26 | $88.58 | 597,600 | |
| $90.54 | -0.55 | -0.6% | $91.07 | $91.07 | $88.95 | 544,300 | |
| $91.09 | +0.81 | +0.9% | $90.14 | $91.90 | $90.14 | 711,666 | |
| $90.28 | -0.50 | -0.6% | $91.00 | $91.51 | $90.05 | 669,640 | |
| $90.78 | +0.51 | +0.6% | $90.25 | $91.04 | $89.38 | 401,800 | |
| $90.27 | -1.71 | -1.9% | $90.94 | $92.00 | $89.70 | 833,700 |
Splits
6 splits since 1991 · NASDAQ:MMSI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 5-for-4 | Split | |
| 4-for-3 | Split | |
| 4-for-3 | Split | |
| 5-for-4 | Split | |
| 5-for-4 | Split | |
| 3-for-2 | Split |
- Ticker
- NASDAQ:MMSI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
Latest earnings call · Oct 29, 2026
Merit Medical Systems (NASDAQ:MMSI) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 22 slides
Latest news
Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry
Nov 5, 2026
Closed $89.62 (-1.1%) on Nov 5, 2026
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance
Oct 29, 2026
Closed $86.24 (-7.7%) on Oct 30, 2026
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
Oct 29, 2026
Closed $86.24 (-7.7%) on Oct 30, 2026
Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026
Oct 6, 2026
Closed $85.09 (+0.2%) on Oct 7, 2026
Merit Medical to Participate in Upcoming Investors Conferences in September
Sep 4, 2026
Closed $89.60 (+1.2%) on Sep 4, 2026
Merit Medical Announces Global Operations Leadership Transition
Aug 19, 2026
Closed $90.27 (-1.9%) on Aug 20, 2026
Merit Medical to Participate in Upcoming Investors Conferences in August
Aug 5, 2026
Closed $87.18 (+1.6%) on Aug 5, 2026
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
Jul 30, 2026
Closed $85.01 (+2.0%) on Jul 31, 2026
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
Jul 2, 2026
Closed $71.45 (+0.5%) on Jul 6, 2026
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
May 19, 2026
Closed $63.77 (+0.2%) on May 19, 2026
Merit Medical Systems, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 19 in the last 12 months · 155 in all · newest Nov 5, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Oct 29, 2026
- Decks
- 61 decks · latest Oct 29, 2026
Where Merit Medical Systems, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MMSI · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:882361 | LS Exchange | Germany | EUR |
| gettex:MM3 | gettex | Germany | EUR |
| Lang & Schwarz:882361 | Lang & Schwarz | Germany | EUR |
| BX Swiss:MMSI | BX Swiss | Switzerland | CHF |
| BOATS:MMSI | BOATS | United States | USD |
| Dusseldorf:MM3 | Dusseldorf | Germany | EUR |
| Frankfurt:MM3 | Frankfurt | Germany | EUR |
| Munich:MM3 | Munich | Germany | EUR |
| Stuttgart:MM3 | Stuttgart | Germany | EUR |
| Tradegate:MM3 | Tradegate | Germany | EUR |
Valuation
P/E 31.6× against a median of 39.3×: 4th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $5.29B USD
- P/E
- 31.6×
- EV/sales
- 3.3×
- EV/EBITDA
- 15.4×
- Price/book
- 2.9×
- Gross margin
- 49.4%
- Operating margin
- 13.5%
- Net margin
- 9.9%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- 0.49
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems, Inc. · NASDAQ:MMSI | US$5.05B | US$5.29B | 31.6× | 3.3× | 15.4× | 2.9× | 9.9% | 0.4× | 0.49 |
| Ypsomed Holding AG · SIX:YPSN | US$6.80B | US$6.76B | 25.7× | 7.8× | 17.3× | 7.2× | 30.4% | 0.0× | n/a |
| ConvaTec Group PLC · LSE:CTEC | US$6.64B | US$8.29B | 37.9× | 3.4× | 15.2× | 4.6× | 7.2% | 1.2× | n/a |
| Cochlear Limited · ASX:COH | US$6.49B | US$6.51B | 66.6× | 4.2× | 24.2× | 5.6× | 6.3% | 0.1× | n/a |
| APT Medical Inc. Class A · SSE:688617 | US$6.00B | US$5.73B | 39.3× | 12.4× | n/a | 11.8× | 33.0% | 0.0× | n/a |
| Haemonetics Corporation · NYSE:HAE | US$5.47B | US$6.35B | 52.7× | 4.6× | 22.1× | 6.1× | 7.5% | 1.3× | 0.27 |
| LivaNova PLC · NASDAQ:LIVN | US$5.00B | US$4.73B | 25.5× | 3.1× | 21.6× | 3.6× | 13.0% | 0.2× | 1.02 |
| Intco Medical Technology Co., Ltd. Class A · SZSE:300677 | US$4.74B | US$3.56B | 106× | 1.8× | n/a | 1.7× | 2.3% | 0.0× | n/a |
| MiniMed Group, Inc. · NASDAQ:MMED | US$4.50B | US$4.30B | n/a | n/a | n/a | 1.2× | n/a | 0.0× | 1.04 |
| ICU Medical, Inc. · NASDAQ:ICUI | US$4.31B | US$5.16B | 71.5× | 2.4× | 16.6× | 2.0× | 2.8% | 0.5× | 0.99 |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A · SZSE:002223 | US$4.19B | US$3.98B | 24.3× | 3.3× | n/a | 2.2× | 14.3% | 0.0× | n/a |
| Median of the others | US$5.23B | US$5.45B | 39.3× | 3.4× | 19.4× | 4.1× | 7.5% | 0.1× | 1.00 |
Forecasts
4 strong buy · 5 buy · 3 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 107.00 USD · Analysts' mean
- EPS, year to Dec 2026
- 4.35 · 11 analysts
- Revenue, year to Dec 2026
- 1.64B · 12 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Martha G. Aronson | President and Chief Executive Officer |
| Raul Parra | Chief Financial Officer |
| Brian G. Lloyd | Chief Legal Officer and Corporate Secretary |
| Pete Dankwerth | Executive Vice President, Global Enterprise Excellence |
| Vicky Brunk | VP, Clinical Affairs |
| Adam Smith | Chief Commercial Officer |
| Mike Voigt | Chief Human Resources Officer |
| Sheri Lewis | Chief Operations Officer |
Board
| Director | Role |
|---|---|
| F. Ann Millner | Chair of the Board |
| Laura S. Kaiser | Compensation, Talent Development Committee, Governance, Sustainability Committee |
| Lonny J. Carpenter | Director |
| Lynne N. Ward | Member - Audit Committee, Finance & Operating Committee |
| Martha G. Aronson | President and Chief Executive Officer |
| Michael McDonnell | Audit Committee |
| Scott R. Ward | Member - Governance & Sustainability Committee, Finance & Operating Committee |
| Silvia M. Perez | Member - Audit Committee, Governance & Sustainability Committee |
| Thomas J. Gunderson | Member, Compensation, Talent Development Committee, Finance, Operating Committee |
Events
Calls
| Call | When | Status |
|---|---|---|
| Merit Medical Systems (NASDAQ:MMSI) Q3 2026 Earnings Call | Thu, Oct 29, 2026 · 4:30 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:30 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q1 2026 Earnings Call | Thu, Apr 30, 2026 · 4:30 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 4:30 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q3 2025 Earnings Call | Thu, Oct 30, 2025 · 5:00 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q2 2025 Earnings Call | Wed, Jul 30, 2025 · 5:00 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q1 2025 Earnings Call | Thu, Apr 24, 2025 · 5:00 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 5:00 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 5:00 PM ET | Replay |
| Merit Medical Systems (NASDAQ:MMSI) Q2 2024 Earnings Call | Thu, Aug 01, 2024 · 5:00 PM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 29, 2026 · After close | −7.7% |
| Q2 2026 | Jul 30, 2026 · After close | +2.0% |
| Q1 2026 | Apr 30, 2026 · After close | −9.1% |
| Q4 2025 | Feb 24, 2026 | −2.9% |
| Q3 2025 | Oct 30, 2025 · After close | +5.4% |
| Q2 2025 | Jul 30, 2025 · After close | +2.3% |
| Q1 2025 | Apr 24, 2025 · After close | −0.1% |
| Q4 2024 | Feb 26, 2025 · After close | −1.9% |
| Q3 2024 | Oct 30, 2024 · After close | +4.0% |
| Q2 2024 | Aug 1, 2024 · After close | +5.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 30, 2024 · After close | +3.4% |
| Q4 2023 | Feb 28, 2024 · After close | −4.9% |
| Q3 2023 | Oct 26, 2023 · After close | +8.7% |
| Q2 2023 | Jul 25, 2023 · After close | −11.1% |
| Q1 2023 | Apr 26, 2023 · After close | +5.3% |
| Q4 2022 | Feb 22, 2023 · After close | +3.8% |
| Q3 2022 | Oct 26, 2022 · After close | +5.6% |
| Q2 2022 | Jul 27, 2022 · After close | +1.6% |
| Q1 2022 | Apr 27, 2022 · After close | −2.4% |
| Q4 2021 | Feb 24, 2022 · After close | +9.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 22 slides | Oct 29, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 22 slides | Oct 29, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 21 slides | Jul 30, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 18 slides | Apr 30, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 21 slides | Feb 24, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 20 slides | Jan 13, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 20 slides | Oct 30, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 20 slides | Jul 30, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 17 slides | Apr 24, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 20 slides | Feb 25, 2025 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2024 Earnings Presentation | Earnings | 20 slides | Oct 30, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 20 slides | Aug 1, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 17 slides | Apr 30, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 20 slides | Feb 28, 2024 |
| JP Morgan Healthcare Conference 2024 | Conference | 27 slides | Dec 7, 2023 |
| Q3 2023 Earnings Presentation | Earnings | 20 slides | Oct 26, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 20 slides | Jul 25, 2023 |
| Merger or Acquisition (June 2023) | Merger or acquisition | 14 slides | Jun 8, 2023 |
| Q1 2023 Earnings Presentation | Earnings | 17 slides | Apr 26, 2023 |
| Q4 2022 Earnings Presentation | Earnings | 20 slides | Feb 22, 2023 |
| Q3 2022 Earnings Presentation | Earnings | 20 slides | Oct 26, 2022 |
| Q3 2022 Earnings Presentation | Earnings | 20 slides | Oct 26, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 20 slides | Jul 27, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 17 slides | Apr 27, 2022 |
| FY2021 Earnings Presentation | Earnings | 21 slides | Feb 24, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 21 slides | Oct 28, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 21 slides | Jul 29, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 18 slides | Apr 29, 2021 |
| FY2020 Earnings Presentation | Earnings | 19 slides | Feb 24, 2021 |
| Investor Presentation (November 2020) | Investor deck | 20 slides | Nov 10, 2020 |
| Q3 2020 Earnings Presentation | Earnings | 21 slides | November 2020 |
| Q2 2020 Earnings Presentation | Earnings | 22 slides | Oct 1, 2020 |
| Q2 2020 Earnings Presentation | Earnings | 22 slides | Jul 29, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 20 slides | Apr 1, 2020 |
| Q4 2019 Earnings Presentation | Earnings | 21 slides | Feb 24, 2020 |
| FY2019 Earnings Presentation | Earnings | 21 slides | 2020 |
| Q3 2019 Earnings Presentation | Earnings | 25 slides | Oct 30, 2019 |
| Q2 2019 Earnings Presentation | Earnings | 22 slides | Jul 25, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 17 slides | Apr 23, 2019 |
| Q4 2018 Earnings Presentation | Earnings | 20 slides | Feb 26, 2019 |
| Q3 2018 Earnings Presentation | Earnings | 15 slides | Oct 25, 2018 |
| Merger or Acquisition (October 2018) | Merger or acquisition | 13 slides | Oct 1, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 23 slides | Jul 23, 2018 |
| Technical Presentation (June 2018) | Technical | 40 slides | June 2018 |
| Technical Presentation (May 2018) | Technical | 25 slides | May 2018 |
| Q1 2018 Earnings Presentation | Earnings | 18 slides | Apr 25, 2018 |
| Investor Presentation (April 2018) | Investor deck | 25 slides | April 2018 |
| Q4 2017 Earnings Presentation | Earnings | 20 slides | Feb 28, 2018 |
| Merger or Acquisition (November 2017) | Merger or acquisition | 9 slides | Nov 16, 2017 |
| Q3 2017 Earnings Presentation | Earnings | 23 slides | Oct 25, 2017 |
This page holds 50 of 61 decks. Open Decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.52B | 1.36B | 1.26B | 1.15B | 1.07B | 963.9M | 994.9M | 882.8M | 727.9M | 603.8M |
| Cost of revenue | 777.6M | 713.2M | 673.5M | 631.9M | 589.4M | 562.7M | 562.5M | 488.0M | 401.6M | 338.8M |
| Gross profit | 738.3M | 643.3M | 583.9M | 519.1M | 485.3M | 401.2M | 432.4M | 394.8M | 326.3M | 265.0M |
| Research and development | 97.4M | 87.5M | 82.7M | 75.5M | 71.2M | 57.5M | 65.6M | 59.5M | 51.4M | 45.2M |
| Selling, general and administrative | 455.2M | 399.7M | 373.7M | 342.5M | 335.7M | 297.7M | 327.3M | 276.0M | 229.1M | 184.4M |
| Operating income | 184.7M | 155.7M | 123.9M | 87.6M | 60.9M | -1.56M | 15.4M | 58.6M | 33.1M | 34.9M |
| Depreciation and amortization | 123.2M | 102.7M | 90.0M | 81.8M | 84.1M | 94.1M | 92.1M | 69.5M | 53.6M | 43.8M |
| EBITDA | 307.9M | 258.4M | 213.9M | 169.4M | 145.0M | 92.5M | 107.5M | 128.2M | 86.7M | 78.6M |
| Interest expense | 26.5M | 31.2M | 15.5M | 6.34M | 5.26M | 9.99M | 12.4M | 10.4M | 7.74M | 8.80M |
| Income before tax | 170.9M | 150.0M | 112.1M | 82.6M | 53.9M | -13.2M | 2.19M | 49.5M | 35.9M | 25.4M |
| Income tax | 42.4M | 29.6M | 17.7M | 8.11M | 5.46M | -3.39M | -3.26M | 7.50M | 8.36M | 5.26M |
| Net income | 128.5M | 120.4M | 94.4M | 74.5M | 48.5M | -9.84M | 5.45M | 42.0M | 27.5M | 20.1M |
| Earnings per share, basic | 2.17 | 2.07 | 1.64 | 1.31 | 0.86 | -0.18 | 0.10 | 0.80 | 0.56 | 0.45 |
| Earnings per share, diluted | 2.13 | 2.03 | 1.62 | 1.29 | 0.84 | -0.18 | 0.10 | 0.78 | 0.55 | 0.45 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 446.4M | 376.7M | 587.0M | 58.4M | 67.8M | 56.9M | 44.3M | 67.4M | 32.3M | 19.2M |
| Receivables | 203.7M | 190.2M | 177.9M | 164.7M | 152.3M | 146.6M | 155.4M | 137.2M | 105.5M | 80.5M |
| Inventory | 333.7M | 306.1M | 303.9M | 266.0M | 221.9M | 198.0M | 225.7M | 197.5M | 155.3M | 120.7M |
| Current assets | 1.04B | 923.8M | 1.11B | 529.1M | 482.2M | 429.7M | 454.5M | 429.8M | 316.1M | 243.4M |
| Property, plant and equipment | 428.4M | 386.2M | 383.5M | 383.0M | 371.7M | 382.7M | 378.8M | 331.5M | 292.8M | 276.6M |
| Goodwill | 506.8M | 463.5M | 382.2M | 359.8M | 361.7M | 363.5M | 353.2M | 335.4M | 238.1M | 211.9M |
| Total assets | 2.69B | 2.42B | 2.33B | 1.66B | 1.65B | 1.66B | 1.76B | 1.62B | 1.11B | 942.8M |
| Current liabilities | 239.8M | 216.4M | 203.6M | 220.6M | 236.3M | 185.0M | 181.7M | 175.3M | 115.6M | 88.3M |
| Long-term debt | 734.0M | 729.6M | 823.0M | 186.8M | 234.4M | 343.7M | 432.0M | 373.2M | 259.0M | 314.4M |
| Total debt | 734.0M | 729.6M | 823.0M | 198.0M | 242.8M | 351.2M | 439.5M | 402.2M | 285.4M | 324.4M |
| Total liabilities | 1.10B | 1.04B | 1.12B | 519.6M | 608.5M | 705.8M | 807.4M | 687.2M | 435.5M | 444.6M |
| Shareholders' equity | 1.58B | 1.38B | 1.20B | 1.14B | 1.04B | 958.6M | 949.9M | 932.8M | 676.3M | 498.2M |
| Shares outstanding | 59.4M | 58.7M | 57.9M | 57.3M | 56.6M | 55.6M | 55.2M | 54.9M | 50.2M | 44.6M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 297.4M | 220.8M | 145.2M | 114.3M | 147.2M | 165.3M | 77.8M | 86.5M | 62.7M | 53.6M |
| Capital spending | -81.7M | -35.1M | -34.3M | -45.0M | -27.9M | -46.0M | -78.2M | -63.3M | -38.6M | -32.8M |
| Free cash flow | 215.7M | 185.7M | 110.9M | 69.3M | 119.3M | 119.3M | -360.0K | 23.2M | 24.1M | 20.8M |
| Cash from investing | -247.4M | -368.7M | -175.3M | -57.4M | -37.2M | -58.7M | -134.5M | -378.8M | -146.8M | -159.1M |
| Cash from financing | 16.0M | -60.0M | 559.3M | -60.3M | -98.4M | -95.7M | 33.5M | 328.3M | 96.5M | 121.1M |
| Change in cash | 69.8M | -210.4M | 528.6M | -7.19M | 10.8M | 12.6M | -23.0M | 35.0M | 13.2M | 15.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 16, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Oct 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 20, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 4, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| S-8 · Registration statement for employee plans | Jun 29, 2026 | Offer document | SEC |
| 11-K · Annual report of an employee plan | Jun 26, 2026 | Annual report | SEC |
| 4 · Change in ownership | Jun 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2026 | Insider trade | SEC |
| 8-K · Current report | May 19, 2026 | Management or board change | SEC |
| 3 · Initial statement of ownership | May 19, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 15, 2026 | Offer document | SEC |
| 4 · Change in ownership | May 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 7, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Apr 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 30, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Apr 13, 2026 | Current report | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 1, 2026 | Current report | SEC |
| ARS · Annual report to shareholders | Mar 31, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 31, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 31, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 8-K · Current report | Jan 8, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 6, 2026 | Other filings | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 13, 2025 | Current report | SEC |
| 8-K · Current report | Nov 3, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Oct 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 17, 2025 | Current report | SEC |
| 8-K · Current report | Oct 9, 2025 | Management or board change | SEC |
| 4/A · Change in ownership, amended | Oct 7, 2025 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Oct 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 22, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 11, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2025 | Results | SEC |
| 8-K · Current report | Jul 11, 2025 | Results | SEC |
| 11-K · Annual report of an employee plan | Jun 27, 2025 | Annual report | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 13, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 12, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 10, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 30, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 30, 2025 | Other filings | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 144 · Notice of proposed sale | May 30, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 27, 2025 | Other filings | SEC |
| 8-K · Current report | May 20, 2025 | Results | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 8-K · Current report | May 19, 2025 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | May 15, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Apr 24, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 24, 2025 | Results | SEC |
| 10-K/A · Annual report, amended | Apr 14, 2025 | Annual report | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 1, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 1, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 1, 2025 | Meeting notice | SEC |
| 144 · Notice of proposed sale | Apr 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 28, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 28, 2025 | Other filings | SEC |
| 8-K · Current report | Feb 25, 2025 | Results | SEC |
| 10-K · Annual report | Feb 25, 2025 | Annual report | SEC |
| 8-K · Current report | Jan 28, 2025 | Current report | SEC |
| 144 · Notice of proposed sale | Jan 14, 2025 | Other filings | SEC |
| 8-K · Current report | Jan 13, 2025 | Results | SEC |
| 8-K · Current report | Dec 19, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Nov 18, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 15, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 12, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 7, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 7, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 5, 2024 | Other filings | SEC |
| 8-K · Current report | Nov 1, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Oct 30, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 30, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 18, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 18, 2024 | Results | SEC |
| UPLOAD · Letter from the SEC | Sep 6, 2024 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Aug 29, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Aug 23, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 13, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 9, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 1, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2024 | Results | SEC |
| CORRESP · Letter to the SEC | Aug 1, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 22, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 12, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jul 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 1, 2024 | Results | SEC |
| 144 · Notice of proposed sale | Jun 28, 2024 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 28, 2024 | Annual report | SEC |
| 4 · Change in ownership | Jun 12, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 10, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 10, 2024 | Other filings | SEC |
| SD · Specialized disclosure | May 31, 2024 | ESG report | SEC |
| CORRESP · Letter to the SEC | May 24, 2024 | Other filings | SEC |
| 8-K · Current report | May 21, 2024 | Material contract | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Merit Medical Systems, Inc.’s releases · as of Oct 27, 2026
- Common shares
- 59,915,044
- Fully diluted
- 59,915,044
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 59,915,044 | Oct 27, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 27, 2026 | 59,915,044 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Martha G. Aronson Other companies: CONMED Corporation (Director · Since at least Feb 23, 2016); Cardiovascular Systems Inc (Director · Feb 20, 2017 – Apr 27, 2023 · Past); Methode Electronics, Inc. (Director · Apr 19, 2016 – Jul 2, 2019 · Past); Ecolab Inc. (EVP & Pres.-Global Healthcare · May 8, 2014 – Aug 1, 2015 · Past); Hill-Rom Holdings Inc (Sr. VP & Pres. N. America · Aug 2, 2010 – Nov 29, 2011 · Past); Hutchinson Technology Inc (Director · Jun 2, 2010 – Oct 5, 2016 · Past); Medtronic plc. (SrVP Chief Talent Officer · Mar 10, 2008 – Oct 30, 2009 · Past) | President and Chief Executive Officer · Since at least Oct 3, 2025 |
| Michael McDonnell Other companies: Moderna, Inc. (Director · Since at least Jul 8, 2026); Baxter International Inc. (Director · Since at least Feb 13, 2026); Biogen Inc. (EVP, Chief Financial Officer · Aug 15, 2020 – Feb 10, 2025 · Past); Frontier Communications Corporation (Director · Dec 12, 2018 – Apr 1, 2019 · Past); IQVIA Holdings, Inc. (EVP and CFO · Dec 16, 2015 – Jul 5, 2020 · Past) | Audit Committee · Since at least May 19, 2022 |
| Scott R. Ward Other companies: InspireMD Inc. (Board Member · Since at least Nov 25, 2024); Cardiovascular Systems Inc (Chairman and CEO, Director · Nov 13, 2013 – Apr 27, 2023 · Past); SurModics Inc (Director · Sep 20, 2010 – Dec 3, 2014 · Past); Medtronic plc. (SVP & Pres CardioVascular · Apr 30, 2010 – Apr 30, 2010 · Past) | Member - Governance & Sustainability Committee, Finance & Operating Committee · Since at least May 13, 2026 |
| David Floyd Other companies: NN, Inc. (Director · May 12, 2016 – Jan 2, 2020 · Past); Stryker Corporation (Group President · Mar 31, 2016 – May 17, 2018 · Past) | Director · Since at least Jun 22, 2020 |
| Sheri Lewis Other companies: SkinHealth Systems Inc. (CSO and COO · Since at least Feb 25, 2025); Avantor, Inc. (EVP, Global Ops & Supply Chain · Dec 31, 2020 – Dec 31, 2023 · Past) | Chief Operations Officer · Since at least Aug 19, 2026 |
| Elizabeth Huebner Other companies: Blue Apron Holdings, Inc. (Director · Jan 3, 2020 – Nov 13, 2023 · Past) | Director · Jan 1, 2019 – Jan 7, 2019 · Past |
| James J Ellis Other companies: Jack Henry & Associates, Inc. (Director · Feb 14, 2006 – Nov 22, 2010 · Past) | Director · Dec 31, 2005 – Aug 11, 2011 · Past |
| Jill Anderson Other companies: Minerva Surgical, Inc. (Director · Oct 21, 2021 – Jun 10, 2022 · Past) | Director · Jan 1, 2019 – Sep 10, 2021 · Past |
| Lonny J. Carpenter Other companies: Novanta Inc. (Director · Since at least Jan 2, 2024) | Director · Since at least May 16, 2024 |
| Stephen C Evans Other companies: Alarm.com Holdings, Inc. (Director · Since at least Feb 1, 2021) | Director · Since at least Jun 17, 2021 |
All 38 people
| Person | Seat |
|---|---|
| Thomas J. Gunderson Other companies: TransMedics Group, Inc. (Director · Since at least May 1, 2019) | Member, Compensation, Talent Development Committee, Finance, Operating Committee · Since at least May 24, 2017 |
| Adam Smith | Chief Commercial Officer · Since at least Apr 1, 2026 |
| B Leigh Weintraub | COO · Dec 28, 2005 – Nov 28, 2006 · Past |
| Brian G. Lloyd | Chief Legal Officer and Corporate Secretary · Since at least Apr 1, 2016 |
| Christian Adam Smith | Chief Commercial Officer · Since at least May 15, 2025 |
| David Ming-Teh Liu | Director · Jul 23, 2016 – Jun 1, 2020 · Past |
| F. Ann Millner | Chair of the Board · Since at least Jul 16, 2015 |
| Franklin J Miller | Director · May 25, 2006 – Mar 11, 2020 · Past |
| Fred P Lampropoulos | Director · Since at least Dec 15, 2005 |
| Greg L Barnett | Chief Accounting Officer · Dec 28, 2005 – Jul 30, 2015 · Past |
| Joseph Wright | CHIEF COMMERCIAL OFFICER · May 22, 2015 – Mar 7, 2024 · Past |
| Justin J Lampropoulos | PRESIDENT, EMEA · May 22, 2015 – Mar 19, 2021 · Past |
| Laura S. Kaiser | Compensation, Talent Development Committee, Governance, Sustainability Committee · Since at least May 19, 2022 |
| Lynne N. Ward | Member - Audit Committee, Finance & Operating Committee · Since at least Aug 13, 2019 |
| Michael E Stillabower | Director · Jun 27, 2007 – Aug 2, 2019 · Past |
| Michel J Voigt | CHIEF HUMAN RESOURCES OFFICER · Since at least Dec 11, 2020 |
| Mike Voigt | Chief Human Resources Officer · Since at least Nov 4, 2026 |
| Neil W Peterson | CHIEF OPERATING OFFICER · Since at least Mar 4, 2024 |
| Nolan E Karras | Director · Nov 5, 2011 – May 27, 2020 · Past |
| Pete Dankwerth | Executive Vice President, Global Enterprise Excellence · Since at least Nov 4, 2026 |
| Raul Parra | Chief Financial Officer · Since at least Dec 23, 2025 |
| Raul Parra Jr | CFO AND TREASURER · Since at least May 29, 2018 |
| Rex C Bean | Director · Dec 31, 2005 – May 21, 2013 · Past |
| Richard W Edelman | Director · Jun 21, 2006 – May 24, 2017 · Past |
| Robert Fredericks | Chief Strategy & Innovation O. · May 20, 2022 – May 20, 2022 · Past |
| Ronald Frost | CHIEF OPERATING OFFICER · Jan 1, 2014 – Aug 10, 2022 · Past |
| Silvia M. Perez | Director · Since at least May 15, 2024 |
| Vicky Brunk | VP, Clinical Affairs · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Merit Medical Systems, Inc.